Transfusion-acquired parasite infection up in U.S.
NEW YORK (Reuters Health) - Since the end of 2005, the US Food and Drug Administration has received nine reports of deaths due to a parasitic infection called babesiosis transmitted by blood transfusions, following nearly a decade in which no cases were reported.
Babesiosis, caused by the parasite Babesia, is usually transmitted through the bite of a tick, the same tick responsible for Lyme disease, although transmission via blood transfusion has also been reported. The disease is hardest on the elderly and people with compromised immune systems.
Doctors should consider babesiosis in immunocompromised patients fever with a history of recent transfusion, Dr. Diane M. Gubernot at the FDA in Rockville, Maryland, and colleagues advise in a report in the medical journal Clinical Infectious Diseases.
Gubernot and colleagues queried FDA safety surveillance systems for trends in babesiosis reporting since 1997. Nine of 10 deaths they uncovered occurred between 2005 and 2008. The patient ages ranged from 43 to 88 years.
Most of the patients developed altered mental status, kidney failure, or respiratory distress, with symptoms appearing anywhere from 2.5 to 7 weeks following blood transfusion. Once symptoms developed, death followed within 5 to 17 days. Implicated blood donations were identified, and all donors tested positive for the infection.
In addition to the nine fatal cases, the number of reports of potential transfusion-transmitted Babesia infection and post-donation babesiosis rose from zero in 1999 to 25 in 2007.
Gubernot and her associates note that Babesia species can survive blood banking procedures, including freezing.
SOURCE: Clinical Infectious Diseases, January 1, 2009.
--------------------------------------------------------------------------------------------Related Posts:
By Will Boggs, MD NEW YORK (Reuters Health) - Clinical recovery is usually satisfactory in children treated for Lyme neuroborreliosis - infection of the nervous system that usually occurs in the late stages — and subsequent fatigue or headache are not attributable to the condition, according to a report in The Pediatric Infectious Disease Journal. Antibiotic treatment
Full Post: Most children recover from Lyme neuroborreliosis
--------------------------------------------------------------------------------------------
WASHINGTON (Reuters) - Researchers say they have developed a cream that might prevent herpes infection for as long as a week — a potentially big step in protecting women from the sexually transmitted infection. The cream uses a new kind of therapy called RNA interference to turn off genes that the virus uses to invade cells,
Full Post: New cream disables herpes virus: study
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - A vaccine to protect against infection with the bird flu virus, the pathogen experts fear is capable of causing pandemic disease in humans, proved safe and effective in a preliminary clinical trial with children, mirroring the results of a recent trial conducted in adults, Hungarian researchers report in the Pediatric
Full Post: Bird flu vaccine protects children
--------------------------------------------------------------------------------------------
NEW YORK (Reuters) - Biogen Idec Inc said on Monday it notified regulators of a new case of a potentially deadly brain disease in a patient being treated with its Tysabri multiple sclerosis drug, the fourth such case reported globally this year. The latest case of the brain infection, known as progressive multifocal leukoencephalopathy (PML), was
Full Post: Biogen says new brain infection linked to Tysabri
--------------------------------------------------------------------------------------------
By Toni Clarke BOSTON (Reuters) - Biogen Idec Inc said on Friday that a multiple sclerosis patient who had been diagnosed with a rare brain infection while taking its drug Tysabri has died, sending the company’s shares down nearly 3 percent. Biogen and its partner Elan Corp Plc disclosed the case in October. Naomi Aoki, a spokeswoman
Full Post: Biogen says Tysabri PML patient dies in U.S.